| Literature DB >> 21430918 |
M Alpha Raj1, A Gopala Reddy, A Rajasekhar Reddy, K Adilaxmamma.
Abstract
A total of 160 White Leghorns of 20 wk age were divided randomly into eight groups. Groups 1, 3, 4 and 5 were fed basal feed and the rest were fed 5% vanaspati supplemented feed until 42 wk of age. From 42 to 54 wk, groups 3, 4 and 5 were fed 1% ferrous sulfate, 100 ppm chlorpyrifos (CPS) and 100 ppm cadmium, respectively, along with basal feed and groups 6, 7 and 8 were fed similar stressors, respectively, along with 5% vanaspati. Groups 1 and 2 served as controls for basal feed and 5% vanaspati feed. Alkaline phosphatase (ALP), alanine transaminase (ALT), total protein, albumin, globulin, A/G ratio, total cholesterol, high density cholesterol (HDL), triglycerides, creatinine, hemagglutination inhibition (HI) titer, and phytohemagglutination (PHA) index were studied. Supplementation of vanaspati resulted in a significant reduction in PHA, cholesterol, albumin and HI titer. Cadmium significantly increased ALP, AST, creatinine and paradoxically increased HDL cholesterol and HI titers. Vanaspati along with cadmium showed similar effects. Administration of CPS lowered PHA index, whereas supplementation along with vanaspati decreased the HI titers and increased the PHA index. Supplementation of vanaspati alone and in combination revealed harmful effects and aggravated the toxicities of CPS and cadmium. Hence, it is concluded that consumption of vanaspati could be harmful.Entities:
Keywords: Immunity; layers; vanaspati; white leghorn
Year: 2011 PMID: 21430918 PMCID: PMC3052581 DOI: 10.4103/0971-6580.75850
Source DB: PubMed Journal: Toxicol Int ISSN: 0971-6580
Marginal means of sero-biochemical parameters in different groups
| Group | Cholesterol (mg/dl) | HDL (mg/dl) | Triglycerides (mg/dl) | Alkaline phosphatase (IU/l) | ALT (IU/l) | Creatinine (mg/dl) | ||
|---|---|---|---|---|---|---|---|---|
| A | ||||||||
| Normal | 111.19±1.06b | 200.36±46.80a | 630.79±1.14b | 200.36±46.80a | 10.76±0.84a | 0.40±0.07ab | ||
| Vanaspati | 103.19±1.06ab | 315.17±46.18abc | 669.24±1.13b | 315.17±46.18abc | 14.67±0.84bc | 0.36±0.07a | ||
| Ferrous sulfate | 99.23±1.06ab | 267.97±47.50ab | 455.65±1.13b | 267.97±47.50ab | 15.08±0.84bc | 0.48±0.07ae | ||
| Chlorpyrifos | 108.88±1.07ab | 445.41±46.18bc | 600.74±1.14b | 445.41±46.18bc | 11.95±0.84ab | 0.40±0.07ad | ||
| Cadmium | 104.01±1.06ab | 672.76±46.18d | 243.48±1.13a | 672.76±46.18d | 18.50±0.84c | 0.58±0.07de | ||
| Ferrous sulfate + vanaspati | 89.81±1.06ab | 524.89±49.30c | 406.72±1.14ab | 524.89±49.30c | 13.51±0.84bc | 0.48±0.07bcde | ||
| Chlorpyrifos + vanaspati | 91.38±1.06ab | 262.48±47.50ab | 660.60±1.13b | 262.48±47.50ab | 14.99±0.84bc | 0.41±0.07ac | ||
| Cadmium + vanaspati | 84.43±1.06a | 613.40±46.18d | 242.78±1.13a | 613.40±46.18d | 18.22±0.84c | 0.64±0.07de | ||
| B | ||||||||
| Vanaspati | 99.22±3.64 | 10.69±1.26NS | 600.05±31.57NS | 323.65±25.55NS | 14.15±2.74NS | 0.47±0.04NS | ||
| Normal | 114.96±3.69 | 11.57±1.28NS | 611.77±32.00NS | 296.68±25.27NS | 20.62±2.80NS | 0.46±0.04NS |
A: effect of individual treatment; B: overall effect of vanaspati supplementation; Values are Mean±SE. Two-way ANOVA followed by Tukey’s Honestly Significant Difference (HSD) post hoc test; Means with different superscripts are significantly different (P<0.05); ALT, alanine transaminase;
Significantly different (P<0.05)
Marginal means of immunological parameters in different groups
| Group | HI (log2) | PHA index (mm) |
|---|---|---|
| A | ||
| Normal | 424.00±103.29b | 0.43±0.05ab |
| Vanaspai | 69.00±30.64a | 0.65±0.06bcd |
| Ferrous sulfate | 432.00±13.13b | 0.47±0.09ac |
| Chlorpyrifos | 512.00±125.69b | 0.42±0.10a |
| Cadmium | 1536.00±193.52c | 0.63±0.09bcd |
| Ferrous sulfate + vanaspai | 62.00±11.49a | 0.75±0.18bcd |
| Chlorpyrifos + vanaspai | 114.00±25.20a | 0.82±0.06d |
| Cadmium + vanaspai | 82.50±18.68a | 0.56±0.09ad |
| B | ||
| Vanaspai | 81.86±11.35 | 0.69±0.06* |
| Normal | 726.00±107.96* | 0.49±0.04 |
A: effect of individual treatment; B: overall effect of vanaspati supplementation; Values are Mean±SE. Two-way ANOVA followed by Tukey’s HSD post hoc test; Means with different superscripts are significantly different (P<0.05); HI, hemagglutination inhibition; PHA, phytohemagglutination
Marginal means of sero-biochemical parameters in different groups
| Group | Protein (g/dl) | Albumin (g/dl) | Globulin (g/dl) | A/G ratio |
|---|---|---|---|---|
| A | ||||
| Normal | 6.05±1.04NS | 1.70±0.04NS | 4.34±1.05NS | 0.40±0.02NS |
| Vanaspai | 6.01±1.04NS | 1.65±0.04NS | 4.33±1.05NS | 0.40±0.02NS |
| Ferrous sulfate | 5.37±1.04NS | 1.63±0.04NS | 3.70±1.05NS | 0.46±0.02NS |
| Chlorpyrifos | 5.89±1.04NS | 1.68±0.04NS | 4.20±1.06NS | 0.40±0.02NS |
| Cadmium | 5.95±1.04NS | 1.73±0.04NS | 4.20±1.05NS | 0.42±0.02NS |
| Ferrous sulfate + vanaspai | 5.51±1.04NS | 1.58±0.04NS | 3.91±1.05NS | 0.41±0.02NS |
| Chlorpyrifos + vanaspai | 5.77±1.04NS | 1.61±0.04NS | 4.12±1.05NS | 0.41±0.02NS |
| Cadmium + vanaspai | 5.32±1.04NS | 1.56±0.04NS | 3.75±1.05NS | 0.42±0.02NS |
| B | ||||
| Vanaspai | 5.83±0.013NS | 1.60±0.02 | 4.23±0.13NS | 0.41±0.10NS |
| Normal | 5.96±0.014NS | 1.69±0.02* | 4.27±0.13NS | 0.42±0.10NS |
A: effect of individual treatment; B: overall effect of vanaspati supplementation.; Values are Mean±SE. Two-way ANOVA followed by Tukey’s HSD post hoc test; Means with different superscripts are significantly different (P<0.05)